Prospects in the management of patients with follicular lymphoma beyond first-line therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Haematologica"
DOI: 10.3324/haematol.2021.278717
Abstract: The management of patients with relapsed or refractory follicular lymphoma has evolved markedly in the last decade, with the availability of new classes of agents (phosphoinositide 3-kinase inhibitors, immunomodulators, epigenetic therapies, and chimeric antigen receptor… read more here.
Keywords: therapy; prospects management; follicular lymphoma; management patients ... See more keywords